Picture of Idorsia logo

IDIA Idorsia Income Statement

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for Idorsia, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue60.623.871.835.397.1
Cost of Revenue
Gross Profit90.8
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses432506482648900
Operating Profit-371-482-411-613-803
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-388-485-449-635-820
Provision for Income Taxes
Net Income After Taxes-388-495-445-635-828
Minority Interest
Net Income Before Extraordinary Items
Net Income-386-494-445-635-828
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-386-494-445-635-828
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-3.06-3.71-3.11-3.77-4.67
Dividends per Share